Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. R. Hurst, W. R. Perera, G. C. Donaldson, G. W. Hagan, J. A. Wedzicha (London, United Kingdom). Plasma biomarkers and response to therapy at exacerbation of COPD. Eur Respir J 2007; 30: Suppl. 51, 412

Member's Comments

No comment yet.

Related content which might interest you: Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Changes in EBC cytokine pattern during treatment of COPD exacerbation Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Changes in urinary biomarkers between stable state and exacerbation of COPD Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 CRP as predictor as predictor for late treatment failure in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020